Published date: 27 August 2025

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 31 March 2025, 12pm

Contract summary

Industry

  • Blood-testing reagents - 33696200

Location of contract

LS1 4AP

Value of contract

£1,677,290

Procurement reference

CF-3150800D0O000000rwimUAA

Published date

27 August 2025

Closing date

31 March 2025

Closing time

12pm

Contract start date

1 April 2025

Contract end date

31 March 2027

Contract type

Service contract

Procedure type

Call-off from a framework agreement

A mini-competition or direct purchase from a pre-established framework agreement.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

Newborn Blood Spot screening (NBS) is a national programme offered to all babies born in the UK, and it currently screens for 9 rare but potentially lethal conditions. The blood spot screening sample is taken from the baby's heel collected on a filter paper dried blood spot (DBS) card. The blood sample is analysed by one of 13 newborn screening laboratories in England

Award information

Awarded date

31 March 2025

Contract start date

1 April 2025

Contract end date

31 March 2027

Total value of contract

£1,677,290

This contract was awarded to 1 supplier.

Revvity (UK) Limited

Address

Llantrisant Business Park,
Llantrisant,
Pontyclun,
Rhondda Cynon Taff CF72 8YW

Reference

None

Supplier is SME?

Yes

About the buyer

Contact name

Claire Burns

Address

7 & 8 Wellington Place
Leeds
LS1 4AP
United Kingdom

Email

claire.burns1@nhs.net